Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» September 2011
September 2011
FDA Biosimilar Guidelines Complete, Awaiting Publication
FDA Biosimilar Guidelines Complete, Awaiting Publication
Patent Docs
FDA
biosimilars
Human Genome Sciences stock falls as Britain denies funding for Benlysta
Human Genome Sciences stock falls as Britain denies funding for Benlysta
Bizjournals.com
Human Genome Sciences
UK
Benlysta
lupus
GSK
Takeda Completes Acquisition and Names New CEO of Nycomed
Takeda Completes Acquisition and Names New CEO of Nycomed
PR Newswire
Takeda
Nycomed
M&A
Pfizer, Roche, Novartis lead the way for Big Pharma in Japan
Pfizer, Roche, Novartis lead the way for Big Pharma in Japan
Fierce Pharma
Japan
Pfizer
Roche
Novartis
Pharmasset Shares Surge on New Hep C Data
Pharmasset Shares Surge on New Hep C Data
TheStreet.com
Pharmasset
hepatitis C
PSI-7977
Investors Guide to the New PDUFA
Investors Guide to the New PDUFA
Motley Fool
PDUFA
investors
ViroPharma pays Intellect Neurosciences $6.5 million for drug molecule rights
ViroPharma pays Intellect Neurosciences $6.5 million for drug molecule rights
Yahoo/AP
ViroPharma
Intellect Neurosciences
Friedreich's Ataxia
OX1
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Yahoo/AP
Array
lung cancer
selumetinib
AstraZeneca
[video] The Next Big Thing In Biotech: Hep C Drugs
[video] The Next Big Thing In Biotech: Hep C Drugs
TheStreet.com
hepatitis C
Inhibitex
Vertex
Indenix
Pharmasset
Add-on depression meds a bright spot in eroding market
Add-on depression meds a bright spot in eroding market
Fierce Pharma
antidepressants
Eli Lilly
Forest Labs
Pfizer
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »